252 replies to this topic

[ImmInst]

Healthcare Movers: MannKind Corporation, CytRx, Lexicon Pharmaceuticals ...
Proactive Investors USA & Canada - 4 hours ago

U.S. stocks fell on Thursday and the Nasdaq hit session lows following an unexpected release of quarterly results from Google Inc that pushed its stock down more than 10 percent.

View the full article

[ImmInst]

Healthcare Gainers (GERN, NVAX, DCTH, QCOR, DNDN)
Mesh Press (press release) - Oct 19, 2012

NEW YORK, October 19,2012 (MESHPRESS) - Marketsareopen, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Top NYSE Active Stocks:-.

View the full article

[ImmInst]

BIOTIME, INC. : Issues Open Letter to Shareholders of Geron Corporation
4-traders - Oct 18, 2012

BioTime, Inc. : Issues Open Letter to Shareholders of Geron Corporation. 10/18/2012| 09:15am US/Eastern. BioTime, Inc. (NYSE MKT: BTX) today issued the following letter to the shareholders of Geron Corporation (Nasdaq: GERN) regarding Geron's stem ...

View the full article

[ImmInst]

Geron Announces Conference Call to Discuss Third Quarter 2012 Financial ...
Reuters - 3 hours ago

Menlo Park, Calif., October 23, 2012 - Geron Corporation (Nasdaq: GERN) will announce its financial results for the third quarter ended September 30, 2012 on Tuesday, October 30, 2012, after the market close.

View the full article

[ImmInst]

Geron Corporation Reports 2012 Third Quarter Financial Results and Events
Reuters - 1 hour ago

MENLO PARK, Calif., October 30, 2012 -- Geron Corporation (Nasdaq: GERN) today reported financial results for the three and nine months ended September 30, 2012.

View the full article

[ImmInst]

Geron Corporation Reports 2012 Third Quarter Financial Results and Events
Reuters - Oct 30, 2012

MENLO PARK, Calif., October 30, 2012 -- Geron Corporation (Nasdaq: GERN) today reported financial results for the three and nine months ended September 30, 2012.

View the full article

[ImmInst]

Geron Posts Narrower Loss
Zacks.com - Oct 31, 2012

Geron Corporation (GERN - Analyst Report) posted a net loss of 13 cents per share in the third quarter of 2012, narrower than the Zacks Consensus Estimate of a loss of 14 cents and the year-ago loss of 16 cents.

View the full article

[ImmInst]

Celsion (NASDAQ:CLSN) Reports Narrower Loss in the Third Quarter – CLSN ...
eStocksDaily - 3 hours ago

Celsion Corporation (NASDAQ:CLSN) announced a loss of $6.0 million or $0.18 a share in the third quarter on Monday, evaluated against $6.4 million or $0.25 a share in the similar three months period previous year.

View the full article

[ImmInst]

Geron Announces Non-Binding Letter of Intent with BioTime Regarding Stem ...
Reuters - 1 hour ago

Thu Nov 15, 2012 4:15pm EST. MENLO PARK, Calif., November 15, 2012 -- Geron Corporation (Nasdaq: GERN) today announced that the company has entered into a non-binding letter of intent (LOI) with BioTime, Inc. (NYSE: BTX) and BioTime's recently ...

BioTime Reaches Non-Binding LoI With Geron On Stem Cell Assets - Quick Facts - NASDAQ
BIOTIME, INC. : BioTime and BioTime Acquisition Corporation Announce ... - 4-traders

View the full article

[ImmInst]

Geron Announces Non-Binding Letter of Intent with BioTime Regarding Stem ...
Reuters - Nov 15, 2012

MENLO PARK, Calif., November 15, 2012 -- Geron Corporation (Nasdaq: GERN) today announced that the company has entered into a non-binding letter of intent (LOI) with BioTime, Inc. (NYSE: BTX) and BioTime's recently formed subsidiary, BioTime ...

View the full article

[ImmInst]

BIOTIME, INC. : BioTime CEO Dr. Michael West Presents Product Development ...
4-traders - 1 hour ago

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, Ph.

View the full article

[ImmInst]

Geron to Discontinue Development of GRN1005; to Cut 64 Full-Time Positions
Benzinga - Dec 3, 2012

Geron Corporation (Nasdaq: GERN) today announced that the company has discontinued development of GRN1005, its peptide-drug conjugate designed to treat cancers in the brain.

View the full article

[ImmInst]

GERON CORPORATION : Geron to Present at the J.P. Morgan Healthcare ...
4-traders - 7 hours ago

MENLO PARK, Calif., January 2, 2013 - Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at 1:00 p.m.

View the full article